Astera Labs (NASDAQ:ALAB) Issues Q1 2026 Earnings Guidance

Astera Labs (NASDAQ:ALAB) updated its first quarter 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.530-0.540 for the period, compared to the consensus earnings per share estimate of 0.430. The company issued revenue guidance of $286.0 million-$297.0 million, compared to the consensus revenue estimate of $260.1 million.

Astera Labs Price Performance

Shares of ALAB traded down $4.81 during mid-day trading on Tuesday, reaching $182.86. The company had a trading volume of 8,276,328 shares, compared to its average volume of 5,162,657. The company has a market capitalization of $30.89 billion, a P/E ratio of 164.74, a P/E/G ratio of 2.32 and a beta of 1.51. Astera Labs has a twelve month low of $47.13 and a twelve month high of $262.90. The company’s 50-day moving average is $164.63 and its 200-day moving average is $174.20.

Analyst Ratings Changes

ALAB has been the subject of a number of analyst reports. Citigroup reissued an “outperform” rating on shares of Astera Labs in a report on Tuesday, December 9th. Morgan Stanley reissued an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a report on Wednesday, December 3rd. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a research report on Wednesday, January 21st. Raymond James Financial started coverage on shares of Astera Labs in a report on Friday, November 21st. They set a “hold” rating for the company. Finally, Stifel Nicolaus boosted their target price on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $190.63.

Insider Buying and Selling

In other news, CFO Michael Truett Tate sold 11,430 shares of the business’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the completion of the sale, the chief financial officer owned 192,297 shares in the company, valued at $27,823,452.93. The trade was a 5.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Sanjay Gajendra sold 90,459 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief operating officer directly owned 1,599,750 shares in the company, valued at $231,467,827.50. This trade represents a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 576,936 shares of company stock worth $87,409,540. 12.50% of the stock is currently owned by company insiders.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Reported Q4 results topped estimates: EPS $0.58 vs. $0.51 consensus and revenue $270.6M vs. $249.5M consensus — signaling strong near-term demand and healthy margins. Earnings Press Release
• Positive Sentiment: Company posted record quarterly and full‑year revenue ($270.6M Q4; $852.5M FY2025, +115% YoY) and is ramping its Scorpio X‑Series platform — supportive for longer‑term growth expectations. GlobeNewswire Release
• Positive Sentiment: Strategic R&D expansion — new Israel design center led by industry veterans (Guy Azrad, Ido Bukspan) to accelerate AI fabric and high‑bandwidth connectivity work, increasing engineering capacity and ecosystem access. Israel R&D Center Article
• Neutral Sentiment: Macro tailwind: analyst commentary highlights large AI infrastructure CAPEX cycles that benefit connectivity suppliers — positive industry backdrop but not company‑specific. Zacks CAPEX Article
• Neutral Sentiment: Reported short interest data shows effectively zero short position/days‑to‑cover (likely reporting artifact) — indicates limited short pressure but data appears noisy.
• Neutral Sentiment: Institutional ownership moves are mixed but large holders (e.g., BlackRock) increased positions materially in recent quarters — provides structural demand but also concentration risk.
• Negative Sentiment: Management’s Q1 guidance was cautious and described as dampening the strong Q4 beat — guidance softness is the primary near‑term catalyst for the share decline. Investing.com Coverage
• Negative Sentiment: CFO transition announced (new CFO Desmond Lynch; outgoing CFO Mike Tate to Strategic Advisor) — leadership change during a growth ramp can create near‑term uncertainty for investors. MSN CFO Transition
• Negative Sentiment: Extensive insider selling over recent months (numerous senior executives sold large blocks, no purchases reported) — can be interpreted negatively by the market.

Hedge Funds Weigh In On Astera Labs

Institutional investors have recently modified their holdings of the stock. Amundi raised its holdings in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the period. Voloridge Investment Management LLC acquired a new stake in shares of Astera Labs in the 3rd quarter valued at about $131,539,000. Holocene Advisors LP acquired a new stake in shares of Astera Labs in the 2nd quarter valued at about $55,827,000. State Street Corp raised its stake in shares of Astera Labs by 39.3% in the 2nd quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after purchasing an additional 604,363 shares during the period. Finally, Qube Research & Technologies Ltd bought a new stake in shares of Astera Labs in the third quarter valued at about $111,291,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.